Katherine Davis / Axios:
Pathos AI, which uses AI to develop oncology drugs, raised a $365M Series D at a $1.6B valuation, bringing its total funding to $467M, per PitchBook — Pathos AI, a New York drug development startup, raised $365 million in a Series D at a $1.6 billion valuation.
Leave a Reply